MHRA / JCVI presser: Jonathan Van Tam says he is about to announce "a change in course, a course correction to the UK programme."
Under 30s will be offered vaccines other than AZ.
This is *more cautious* than the EMA recommendation to continue on with all age groups that we heard just minutes ago.
This is *more cautious* than the EMA recommendation to continue on with all age groups that we heard just minutes ago.
MHRA/JCVI: More work is needed to confirm if the vaccine has caused these very rare side effects.
MHRA/JCVI: Benefits of AZ vaccine continue to outweigh the risks for the vast majority of people.
The balance of risks is "very favourable for older people, but it is more finely balanced for younger people."
The balance of risks is "very favourable for older people, but it is more finely balanced for younger people."
• • •
Missing some Tweet in this thread? You can try to
force a refresh
